New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—
Sep '25 Mar '25 Sep '24 Mar '24 Older periods
Current Ratio
8.09 11.04 0.64 0.09

+8 more quarters

Net Debt/EBITDA
4.78 — 1.70 —
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 —
Operating CF/Net income
— — — 0.00
Capex/Depreciation
(0.08) — (3.56) (28.50)
Interest Coverage
(537.96) — (312.73) —
Intangible Assets out of Total Assets
0.00 0.00 0.00 —
Share Based Compensation of Revenue
0.00% — 0.00% —
Free Cash Flow per Share
— — — 0.00
Cash per Share
30.37 — 350.38 —
Shareholders Equity per Share
50.07 — (224.12) —
Interest Debt per Share
0.00 — 0.00 —
Book value per Share
50.07 — (224.12) —
Free Cash Flow
(2.03) — (1.52) (2.95)
Working Capital
6.69 5.97 (1.27) (10.98)
Capital Expenditures
0.00 — (0.01) (0.01)
Net Current Asset Value
6.69 5.97 (1.27) (10.98)
Other line items
Quick Ratio
7.82 10.61 0.59 0.07
Operating CF per Share
— — — 0.00
Capex per Share
— — — 0.00
Average Receivables
0.11 0.10 0.09 0.44
Average Assets
14.61 133.12 129.37 129.47
Average Common Equity
4.19 4.09 0.13 116.84
Capex to Sales
0.00 — 0.00 0.00

Fold the line items

Columns are period end dates